UnitedHealth Group Incorporated $UNH Stock Holdings Lifted by Kinsale Capital Group Inc.

Key Points

• Kinsale Capital Group increased its UnitedHealth position by 13.4% in the second quarter, bringing its holdings to 38,510 shares valued at approximately $16 million. Institutional investors collectively own 87.86% of UnitedHealth’s stock.
• UnitedHealth reported quarterly earnings of $6.38 per share, exceeding estimates by $1.44, while revenue reached $112.03 billion. The company maintained fiscal 2026 earnings guidance of $19.50–$20.00 per share.
• Analysts remain broadly positive, with a “Moderate Buy” consensus and an average price target of $455.92, while UnitedHealth declared a quarterly dividend of $2.32 per share. However, shareholder and derivative lawsuits involving governance, cybersecurity, billing audits and AI-driven claim denials present ongoing risks.

Kinsale Capital Group Inc. lifted its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.4% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 38,510 shares of the healthcare conglomerate's stock after acquiring an additional 4,557 shares during the quarter. UnitedHealth Group makes up about 2.1% of Kinsale Capital Group Inc.'s holdings, making the stock its 10th biggest holding. Kinsale Capital Group Inc.'s holdings in UnitedHealth Group were worth $16,006,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of UNH. LFG Wealth Partners LLC grew its holdings in shares of UnitedHealth Group by 3.3% during the second quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate's stock valued at $355,000 after buying an additional 27 shares in the last quarter. Synergy Financial Group LTD boosted its position in UnitedHealth Group by 3.1% during the 2nd quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate's stock worth $369,000 after acquiring an additional 27 shares during the period. Ares Financial Consulting LLC increased its holdings in shares of UnitedHealth Group by 7.2% in the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate's stock valued at $174,000 after purchasing an additional 28 shares during the period. Rockland Trust Co. grew its position in UnitedHealth Group by 1.1% during the second quarter. Rockland Trust Co. now owns 2,589 shares of the healthcare conglomerate's stock valued at $1,076,000 after purchasing an additional 29 shares in the last quarter. Finally, Matrix Trust Co lifted its position in UnitedHealth Group by 24.8% in the 2nd quarter. Matrix Trust Co now owns 146 shares of the healthcare conglomerate's stock worth $61,000 after buying an additional 29 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 500 shares of UnitedHealth Group stock in a transaction dated Wednesday, August 5th. The stock was sold at an average price of $410.00, for a total value of $205,000.00. Following the transaction, the chief executive officer directly owned 16,497 shares in the company, valued at approximately $6,763,770. The trade was a 2.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.19% of the company's stock.

UnitedHealth Group Stock Down 1.7%

Shares of UNH stock opened at $395.02 on Tuesday. The stock's 50 day simple moving average is $415.52 and its 200 day simple moving average is $353.65. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78. The company has a market capitalization of $354.57 billion, a price-to-earnings ratio of 25.42, a PEG ratio of 1.40 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The company had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. During the same quarter last year, the company posted $4.08 earnings per share. The company's revenue for the quarter was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 19.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be given a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group's payout ratio is currently 59.72%.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on UNH shares. Barclays upped their price target on shares of UnitedHealth Group from $429.00 to $441.00 and gave the stock an "overweight" rating in a research note on Monday, July 20th. Leerink Partners upped their target price on UnitedHealth Group from $400.00 to $462.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 17th. Morgan Stanley lifted their price target on UnitedHealth Group from $468.00 to $529.00 and gave the company an "overweight" rating in a report on Friday, July 17th. HSBC raised their price objective on shares of UnitedHealth Group from $300.00 to $380.00 and gave the company a "hold" rating in a research report on Monday, July 6th. Finally, KeyCorp increased their price target on shares of UnitedHealth Group from $400.00 to $475.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 14th. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and an average price target of $455.92.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth authorized a dividend, reinforcing shareholder returns and signaling confidence in its financial position. However, the announcement comes amid an ongoing governance lawsuit, which may limit its positive impact. UnitedHealth Group Authorizes Dividend Amid Governance Lawsuit
• Positive Sentiment: Wall Street’s average brokerage recommendation remains favorable, suggesting analysts believe UnitedHealth’s valuation and earnings outlook could support the shares. The bullish view is tempered by the tendency of sell-side recommendations to skew optimistic. Wall Street Bulls Look Optimistic About UnitedHealth
• Neutral Sentiment: The expected guilty plea by Luigi Mangione in the federal case involving the killing of UnitedHealthcare CEO Brian Thompson could bring additional clarity to a high-profile event, but it does not materially change UnitedHealth’s operating outlook. Luigi Mangione Reportedly Set to Plead Guilty
• Negative Sentiment: A shareholder lawsuit alleges UnitedHealth misled investors, failed to address governance and cybersecurity weaknesses, and discontinued an internal Medicare billing audit before the Change Healthcare cyberattack. The claims increase potential legal, regulatory and reputational risks. Investor Suit Says UnitedHealth Ignored Governance and Cybersecurity Gaps
• Negative Sentiment: A derivative lawsuit reportedly says executives knew that patients won roughly 90% of appeals against AI-generated claim denials. The allegation raises concerns about the accuracy of automated utilization management, potential compliance costs and damage to UnitedHealth’s reputation. UNH Patients Win 90% of AI Denial Appeals
• Negative Sentiment: An investor analysis argues that margin recovery is already reflected in UnitedHealth’s valuation, leaving future earnings growth as the next major test. This limits upside if revenue or membership growth disappoints. UnitedHealth Margin Recovery Is Priced In

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source